These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12852147)

  • 1. [Prostate-specific antigen in the diagnosis and treatment of carcinoma of the prostate].
    Cerović S; Dimitrijević J; Milović N; Ajdinović B; Knezević-Usaj S; Popović L; Brajusković G
    Vojnosanit Pregl; 2002; 59(6 Suppl):53-7. PubMed ID: 12852147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of clinically localized prostate cancer. Part I--observation or treatment?].
    Szelachowska J; Kornafel J; Gisterek I
    Pol Merkur Lekarski; 2006 Dec; 21(126):594-7. PubMed ID: 17405305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostate specific antigen (PSA) in the diagnosis and treatment of prostate carcinoma: advances and controversies].
    Popov I; Radosevic-Jelic Lj
    Srp Arh Celok Lek; 2001; 129(5-6):159-62. PubMed ID: 11797466
    [No Abstract]   [Full Text] [Related]  

  • 4. [Uncommon initial symptoms of metastasized carcinoma of the prostate].
    Wymenga LF; Mensink HJ
    Ned Tijdschr Geneeskd; 1999 Oct; 143(42):2081-6. PubMed ID: 10560555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Math may help to guide future prostate cancer treatments.
    Printz C
    Cancer; 2012 Mar; 118(5):1177. PubMed ID: 22344616
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate carcinoma practice patterns: what do they tell us about the diagnosis, treatment, and outcomes of patients with prostate carcinoma?
    Wilt TJ
    Cancer; 2000 Mar; 88(6):1277-81. PubMed ID: 10717606
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for prostate carcinoma: prostate-specific antigen--friend or foe?
    D'Amico AV
    Cancer; 2005 Mar; 103(5):881-3. PubMed ID: 15637686
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostate carcinoma: prostate-specific antigen--and then what?].
    Schmid HP
    Ther Umsch; 1998 Jul; 55(7):426-8. PubMed ID: 9702110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostatic carcinoma in a young adult: a case report].
    Yamamoto S; Senzaki A; Yamagiwa K; Tanaka T; Oda T
    Hinyokika Kiyo; 1990 May; 36(5):617-22. PubMed ID: 1698013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
    Bastian PJ; Stief CG
    MMW Fortschr Med; 2010 May; 152(19):36. PubMed ID: 20556999
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for prostatic carcinoma.
    van Heyningen C
    Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():335-6. PubMed ID: 9547920
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening asymptomatic, middle-aged men for carcinoma of the prostate: can we all stop shouting out our answer for a minute and think about the question?
    Whittington R
    Med Pediatr Oncol; 1999 Jan; 32(1):60-2. PubMed ID: 9917756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostate-specific membrane antigen and its role in diagnosis of prostate cancer].
    Chekhonin VP; Grigor'ev ME; Zhirkov IuA; Lebedev DV
    Vopr Med Khim; 2002; 48(1):31-43. PubMed ID: 12068496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate carcinoma].
    Huland H
    Dtsch Med Wochenschr; 1994 Apr; 119(16):605. PubMed ID: 7512895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
    Hübler J; Jávor A
    Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
    Kantoff PW; Talcott JA
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
    Andriole GL; Kibel AS
    Cancer; 2011 Mar; 117(6):1110-2. PubMed ID: 20960524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Summary of our clinical experience with the determination of serum prostate-specific antigen level in the first five years].
    Bánfi G; Kiss F; Kádár A; Romics I
    Magy Onkol; 2003; 47(2):165-8. PubMed ID: 12975664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Belpomme D; Irigaray P
    J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
    [No Abstract]   [Full Text] [Related]  

  • 20. What is 'insignificant' prostate carcinoma?
    Klein EA
    Cancer; 2004 Nov; 101(9):1923-5. PubMed ID: 15372479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.